Skip to content

Clinical trials

Hepatoblastoma trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hepatoblastoma Country / region: United States Clear all

53 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20041
20052
20081
20091
20101
20115
20131
20152
20178
20186
20191
20203
20216
20224
20231
20253

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed20
Active, not recruiting14
Recruiting11
Terminated4
Withdrawn1
No longer available1
Suspended1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)16
Children's Oncology Group7
Emory University4
Masonic Cancer Center, University of Minnesota3
Memorial Sloan Kettering Cancer Center3
Seattle Children's Hospital3
Children's Hospital Medical Center, Cincinnati2
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins2
St. Jude Children's Research Hospital2
Ann & Robert H Lurie Children's Hospital of Chicago1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hepatoblastoma53
Neuroblastoma36
Wilms Tumor33
Rhabdomyosarcoma32
Osteosarcoma31
Sarcoma29
Sarcoma, Ewing27
Rhabdoid Tumor26
Medulloblastoma24
Neuroectodermal Tumors, Primitive, Peripheral20

Trials

Showing 26 to 50 of 53. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.